APA (7th ed.) Citation

S, N., U, M., J, M., J, N., S, N., S, K., . . . JM, W. (2025). Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma. Leukemia, 39(10), 2563. https://doi.org/10.1038/s41375-025-02757-6

Chicago Style (17th ed.) Citation

S, Neubert, et al. "Plasmapheresis Facilitates Soluble BCMA Clearance and Contributes to Reversing Primary Resistance to Anti-BCMA Immunotherapy in Multiple Myeloma." Leukemia 39, no. 10 (2025): 2563. https://doi.org/10.1038/s41375-025-02757-6.

MLA (9th ed.) Citation

S, Neubert, et al. "Plasmapheresis Facilitates Soluble BCMA Clearance and Contributes to Reversing Primary Resistance to Anti-BCMA Immunotherapy in Multiple Myeloma." Leukemia, vol. 39, no. 10, 2025, p. 2563, https://doi.org/10.1038/s41375-025-02757-6.